Skip to content

Dr. Anemoon Torfs

Active
Private limited companyfounded 20233 yrs activeVestinglaan 2, 2860 Sint-Katelijne-Waver, BelgiumKBO/BCE: BE 0803.128.326
Summary

Dr. Anemoon Torfs has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €299,235 and a net result of €155,147. Its solvency ranks better than 69% of 20346 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
€377,210total assets 2025
Equity
€299,235
Profit
€155,147
Turnover not published (abridged schema)
Financial health
98 Excellent Checked score 2025
Bankruptcy chance 12 m
< 0.1%
Structure
Accounts 15 d early1 of 2 deeds read
Why 98+ Sector Human health activities (NACE 86)+ Liquidity: current ratio 4.93, cash €283,400+ Size: total assets €377,210+ Equity €299,235 (79.3% of total assets)Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Better than 83% of its sector peers (NACE 86, micro)
Performance against the sector, not lower risk
Financial strength · tick = 2024
Strong
Solvency 100+14
equity 79.3% of total assets
Liquidity 94+12
short-term debt 20.1% · cash 75.1%
Profitability 100=
return on assets 41.1%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (23,961 companies)
Last 24 months 11-2024: 0.3% 12-2024: 0.4%▲ +8.7% vs 11-2024highest value 01-2025: 0.4%● 0.0% vs 12-2024highest value 02-2025: < 0.1%▼ -92.3% vs 01-2025 03-2025: < 0.1%▲ +3.7% vs 02-2025 04-2025: < 0.1%▼ -3.6% vs 03-2025 05-2025: < 0.1%● 0.0% vs 04-2025 06-2025: < 0.1%▲ +3.7% vs 05-2025 07-2025: < 0.1%● 0.0% vs 06-2025 08-2025: < 0.1%● 0.0% vs 07-2025 09-2025: < 0.1%▲ +10.7% vs 08-2025 10-2025: < 0.1%● 0.0% vs 09-2025 11-2025: < 0.1%● 0.0% vs 10-2025 12-2025: < 0.1%▲ +3.2% vs 11-2025 01-2026: < 0.1%▲ +9.4% vs 12-2025 02-2026: < 0.1%▼ -42.9% vs 01-2026 03-2026: < 0.1%● 0.0% vs 02-2026 04-2026: < 0.1%● 0.0% vs 03-2026 05-2026: < 0.1%● 0.0% vs 04-2026 06-2026: < 0.1%● 0.0% vs 05-2026 07-2026: < 0.1%▼ -5.0% vs 06-2026lowest value 08-2026: < 0.1%● 0.0% vs 07-2026lowest value 09-2026: < 0.1%▲ +5.3% vs 08-2026 10-2026: < 0.1%● 0.0% vs 09-2026
  • Sector Human health activities (NACE 86) lowers the probability
  • Liquidity: current ratio 4.93, cash €283,400 lowers the probability
  • Size: total assets €377,210 lowers the probability for this profile
  • Equity €299,235 (79.3% of total assets) lowers the probability
Credit up to €25,000 at 30 days acceptable
Liquidity ample (current ratio 4.93 against 2.53 in 2024; short-term debt: 20.1% and cash: 75.1% of total assets), and 20.7% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 86, micro). Better than this share of them on solvency 82%, liquidity 80%, profitability 80%, growth against the median 91%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 05-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Sector Human health activities (NACE 86)
In the bankruptcy model this factor lowers the probability.
KBO
lowers risk · Liquidity: current ratio 4.93, cash €283,400
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
lowers risk · Size: total assets €377,210
In the bankruptcy model this factor lowers the probability for this profile.
NBB · annual accounts
lowers risk · Equity €299,235 (79.3% of total assets)
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 16-01-2026, 15 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
15 d early
2024
15 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 2 accounts on average 15 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
30-06-2026 close06-10-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Registered officeRegistered-office move · Director in…
  2. Annual accounts filedfiscal year 2025 · micro…
  3. Equity above €200,000Eq €299,235 ▲108%

Key points

  • Positive: Equity rose in 2025from €144,088 to €299,235 ▲ 108% View
  • Positive: Among the best 19% on net resultsector median €60,315 · 20,334 companies €155,147 View
  • Total assets 20252 fiscal years filed €377,210 View

By topic

Financials

Fiscal year
2025
Total assets
€377,210
Profit
€155,147
Solvency
79.3%
Total assets▲ 58.5%
Net result
20242025
Go to Financials

Timeline

Events
4
Since
2025
Next accounts
by 31-01-2027
  1. 18-09-2026Registered office
  2. 16-01-2026Annual accounts filed
  3. 30-06-2025Equity above €200,000
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
24-06-2023
Year ends
30-06
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.